United States · FDA National Drug Code directory
Venlafaxine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-2779_d62baf0c-d78e-42b3-9739-93cb3dcafc53
- Product NDC
- 71335-2779
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- Venlafaxine Hydrochloride
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230925
- Source listing expiry
- 20271231
Source-listed ingredients
- VENLAFAXINE HYDROCHLORIDE — 37.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71335-2779-1) · 71335-2779-1
- 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71335-2779-2) · 71335-2779-2
- 10 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71335-2779-3) · 71335-2779-3
- 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71335-2779-4) · 71335-2779-4
- 14 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71335-2779-5) · 71335-2779-5
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →